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The aim of the research effort entertained herein was to develop, evaluate and fully characterize a 
multiparticulate floating gastroretentive system for the modified release of zidovudine (AZT), an 
antiretroviral drug. AZT was used as a water-soluble model drug at therapeutic doses. The floating 
gastroretentive system was obtained via polymer coating of calcium silicate-adsorbed AZT. The 
proposed system was evaluated in vitro for particle micromorphology, lag time for floating and duration 
of floating, drug loading capacity, drug release profile, and drug release kinetics. The physicochemical 
properties of AZT were evaluated by scanning electron microscopy (SEM) analyses, differential 
scanning calorimetry (DSC) analyses, X-ray diffraction (XRD) analyses, and infrared spectroscopy 
(FTIR) analyses. Results from SEM analysis of the AZT-containing floating gastroretentive granules 
allowed observation of an irregular surface and the apparent absence of pores. Floating of the AZT-
containing gastroretentive granules was immediately achieved, that is lag time for floating was virtually 
zero and duration of floating was higher than 12 h. The drug loading capacity of the floating 
gastroretentive granules was ca. 81.09 ± 14.66%, and the release system thus obtained exhibited an 
extended drug release profile. Results from DSC and XRD analyses showed a modification in the AZT 
solid state, while the FTIR spectroscopy analyses revealed that the chemical structure of AZT remained 
unchanged upon adsorption to calcium silicate followed by polymeric coating. Hence, the coated 
granules produced presented gastroretentive, floating, and extended drug release properties. 
 
Key words: 3-azidothymidine (AZT), cal-sil floating granules, gastroretentive floating system, extended drug 
release, zidovudine (AZT), polymer coating. 
 
 
INTRODUCTION 
 
The gastrointestinal tract (GIT) has a natural physio-
logical and anatomical barrier that makes difficult the 
absorption of drugs after their oral  administration.  Drugs 
with a narrow absorption window are not completely 
absorbed in the upper GIT, namely in the stomach and 
proximal duodenum (Narendra et al., 2006). One possible  
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reason for the poor drug absorption in these anatomical 
segments lies in the relatively short transit time, which is 
mainly due to the gastric emptying rate (Narendra et al., 
2006; Shah et al., 2009). In such cases, the control of 
drug residence time, particularly aiming at increasing 
drug retention time in the stomach, is a valuable resource 
to improve bioavailability (Shah et al., 2009; Arora et al., 
2005). In an effort to minimize bioavailability problems 
following drug delivery by the oral route, several modified 
release systems have been proposed, the aim of which 
was to control the site of, and/or the release rate of 
drugs, while providing reproducible, effective, and safe 
plasmatic concentrations (Shah et al., 2009; Talukder 
and Fassihi, 2004; Lopes et al., 2005; Yoshida et al., 
2011).  
Among the target-directed drug release systems that 
increase the drug retention time, gastroretentive modified 
drug release systems are of particular significance (Arora 
et al., 2005; Soppimath et al., 2001; Garg and Sharma, 
2003). By using such systems, drugs may remain in the 
gastric region for longer periods of time, typically several 
hours. Besides improving the drug bioavailability, 
prolonged gastric retention times reduces drug loss and 
improves the control over plasmatic drug concentration, 
allowing introduction of new therapeutic regimens for 
known drugs with poor bioavailability with concomitant 
substantial benefits to the patients (Garg and Sharma, 
2003). The floating gastroretentive systems (FGS) are 
used to achieve prolonged gastric retention of orally 
administered solid dosage forms (Garg and Sharma, 
2003; Pandya et al., 2011). The use and effectiveness of 
these FGS systems have been evaluated both in vitro 
and in vivo, and also widely discussed in the specialty 
literature (Kawashima et al., 1992; Benita et al., 1990; 
Cui et al., 2003; Sato et al., 2004a, b; Gupta and Pathak, 
2008; Ramachandran et al., 2010; Pandya et al., 2011).  
Jain et al. (2008) investigated the use of ranitidine 
hydrochloride as a model drug adsorbed onto calcium 
silicate doubly coated with hydroxypropylmethylcellulose 
and ethylcellulose dispersions, obtaining a system 
consisting of polymeric-coated granules that exhibited a 
gastroretentive release profile with a flotation duration 
timeframe of 8 h. Both in vitro and in vivo assays demon-
strated the potential of that system for attaining the 
sustained release of the drug when compared with their 
non-floating counterparts. The nucleoside analog 3-
azidothymidine (AZT), or zidovudine, has been shown to 
efficiently block the replication of HIV virus in (in vitro) cell 
culture (Mitsuya et al., 1985; Rachlis, 1990). Subsequent 
studies demonstrated that the AZT action mechanism 
occurs via the selective inhibition of HIV virus reverse 
transcriptase by its triphosphate metabolite. These 
discoveries have established the appearance of the first 
generation   of   antiretroviral   agents:    nucleoside    and 
 
 
 
 
 
nucleotide reverse transcriptase inhibitors (NRTIs) (Cihlar 
et al., 2010). As a viral reverse transcriptase nucleoside 
inhibitor, AZT interferes with the ending of the replicative 
cycle of HIV-1 virus, HIV-2 virus-1 in T cells/lymphoma in 
hu-mans, in other mammalian retroviruses and in 
hepatitis B antiviruses, thus preventing changes in the 
host DNA (Dienstag et al., 1995). The AZT half-life in the 
human body reaches approximately 60 min, with the 
bioavailability of the oral dosage form not exceeding 
60%. However, high daily administration doses (from 400 
mg up to 1200 mg) are usually required due to extensive 
hepatic first-passage metabolism (Klecker et al., 1987; 
Sharma et al., 2008).  
The severe toxicity caused by AZT can be minimized if 
oscillations in its blood plasma level are avoided and if 
the total daily administered dose is reduced (Carvalho et 
al., 2009). The confinement of AZT to the stomach 
through the use of floating gastroretentive delivery sys-
tems is highly reliable in increasing the bioavailability of 
this drug. Hence, the major goal of the research effort 
entertained herein was to optimize, prepare, and fully 
characterize physicochemically, a floating multiparticulate 
gastroretentive system for the extended release of AZT, 
consisting of calcium silicate, ethylcellulose, 
hydroxypropylmethylcellulose and Eudragit
®
 L100. 
 
 
MATERIALS AND METHODS 
 
Reagents 
 
AZT was supplied by Nortec Química S.A. (Duque de Caxias RJ, 
Brazil). Ethylcellulose (Ethocel
® 
100 cp) and 
hydroxypropylmethylcellulose (HPMC) (Methocel K4M
®
) was 
supplied by Colorcon do Brazil Ltda. (Cotia SP, Brazil). Anionic 
copolymers based on methacrylic acid and methyl (Eudragit
®
 L100) 
was supplied by Almapal (São Paulo SP, Brazil). Low density 
calcium silicate (Ca2SiO4 or Cal-Sil) was purchased from Vetec 
Química Fina Ltda. (Duque de Caxias RJ, Brazil). Sodium 
bicarbonate (NaHCO3) was purchased from Dubon Ltda. (São 
Paulo SP, Brazil). All other reagents were of pharmaceutical grade, 
PA grade or better, and the water used was purified in a Milli-Q Plus 
185 system (Molsheim, France) to a final conductivity of ca. 18.2 
M cm
-1
. 
 
 
Experimentals  
 
Preparation of calcium silicate (Cal-Sil) particles with adsorbed 
AZT 
 
Low density Cal-Sil was dispersed into ethanol (1:3 w/v) containing 
0.2 g AZT and 0.25 g sodium bicarbonate, so as to produce a 
slurry. The resulting slurry was ultrasonicated for 10 min at 40°C (in 
a ultrasonicator from UNIQUE
®
, model UC, Indaiatuba, Brazil), so 
as to enhance penetration of the dissolved drug into the core of  
Cal-Sil via particle pores. The excess ethanolic solution was then 
removed by vacuum filtration, followed by drying of the resulting 
particles with adsorbed AZT under vacuum at room temperature.  
*Corresponding author. E-mail: marco.chaud@prof.uniso.br. Tel: +55 (15) 2101 7181. Fax: +55 (15) 2101 7000. 
  
 
 
 
 
Polymer coating the produced granules of calcium silicate with 
adsorbed AZT 
 
Preparation of polymer-coated granules of calcium silicate with 
adsorbed AZT was carried out in two steps: (i) 5 g of Cal-Sil AZT-
sodium 
bicarbonate-adsorbed particles were dispersed in 10 ml of 
Ethylcellulose:Eudragit
®
 L100:HPMC (70:10:20) in ethanolic 
dispersion at 5% (w/v), until production of a cohesive wet mass with 
moldable consistency for further granulation; (ii) 5 g of the primary 
coated granules (PCG) were dispersed in 10 ml of an ethanolic 
dispersion at 5% (w/v) of Ethylcellulose:HPMC (80:20), until 
production of a cohesive wet mass with moldable consistency for 
further regranulation. The granules obtained after the second 
coating process were labeled as SCG. 
 
 
Determination of drug loading efficiency 
 
The drug content of the granules was determined by dispersing ca. 
100 mg of formulation (accurately weighed) into 100 ml ethanol 
under magnetic stirring (set at 200 rpm) for 24 h, to extract AZT. 
Following filtration through a membrane with 0.25 µm pore size, the 
drug concentration was determined spectrophotometrically at a 
wavelength of 266 nm, in a UV-Vis spectrophotometer from 
Shimadzu (model MultiSpec 1501, Tokyo, Japan). All spectro-
photometric determinations were performed in triplicate. Drug 
loading efficiency (particle percent drug loading) was calculated as 
the ratio between the drug determined via interpolation of the 
absorbance readings in an analytical curve (Abs (266 nm = ƒ{[AZT] 
mg/L}) and the drug offered in the preparation of the particles (that 
is, the theoretical drug loading) (Equation 1). 
  
                                Calculated drug loading 
Drug loading (%) =       × 100 
                                Theoritical drug loading 
 
        (1) 
 
 
Determination of buoyancy 
 
Cal-Sil AZT granules (100 mg) were poured in a simulated gastric 
fluid without pepsin (pH 1.2; 37°C; 900 ml) kept in a dissolution 
device equipped with a type-II apparatus (shaft) from American Lab 
(model AL1000, São Paulo, Brazil). Following a 24 h timeframe 
under stirring at 50 rpm, the layer of floating granules was 
separated by filtration and dried in an oven (50°C) until constant 
weight was attained. The resulting dry residue (consisting of floating 
granules) was weighed, and the buoyancy ability was determined in 
sextuplicate by using Equation 2, where Pi is the initial mass of the 
dry coated particles before introduction in the dissolution device, Pf 
is the final mass of the particles gathered (floating layer) after being 
dried in the oven, and mf is the mass of drug released in the 
dissolution medium as measured by UV spectrophotometry 
(Yoshida et al., 2011). 
  
                           Pf + mf 
Buoyancy (%) =               × 100   
                              Pi 
 
                                            (2) 
 
 
Structural microanalysis of the double-coated calcium silicate 
particles with adsorbed AZT, via scanning electron microscopy 
 
The external morphology of the Cal-Sil granules with adsorbed AZT 
was evaluated via scanning  electron  microscopy  (SEM)  analyses  
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using a Stereoscan scanning electron microscope from Leica 
(model Leo 440i, Leica-Zeiss, Cambridge, UK), using a Sputter 
coater from Leica (model SC7620, Cambridge, UK). The samples 
for SEM analysis were prepared by lightly sprinkling the powdered 
particles on an adhesive double face tape kept adhered on an 
aluminium stub. The samples were then sputter-coated with gold to 
a thickness of about 300 Å, under inert (argon) atmosphere with 
high-vacuum evaporator. The samples were randomly scanned, 
photomicrographed at 5 kV, and magnified at ×500 up to ×5000. 
 
 
Infrared spectroscopy, differential scanning calorimetry, and 
X-ray diffraction analyses 
 
The infrared spectra of free AZT and of both coated Cal-Sil 
granules with and without AZT were gathered via use of a KBr 
technique, and recorded on a Fourier transform infrared (FTIR) 
spectrophotometer (from Perkin Elmer, model Spectrum One, 
Shelton CT, USA). The FTIR spectra were obtained by scanning at 
a wavelength ranging from 400 to 4000 cm
−1
. The samples of free 
AZT and of both coated Cal-Sil granules with and without AZT were 
also analyzed by differential scanning calorimetry (DSC) on a 
differential scanning calorimeter from Shimadzu (model DSC-Q100, 
Tokyo, Japan) coupled with a thermal analyzer also from Shimadzu 
(model DTA 50, Tokyo, Japan). Samples weighing ca. 3 mg were 
placed inside aluminum pans, duly sealed, and subject to a heating 
cycle from 30 to 350°C at a constant heating rate of 10°C min
-1
 
under inert (nitrogen) atmosphere. The X-ray diffractograms of 
samples of free AZT and of both coated Cal-Sil granules with and 
without AZT were obtained on an X-ray diffractometer from 
Siemens (model D5000, Munich, Germany) using filtered Ni and 
CuKα radiation. Analyses were performed at a diffraction angle of 
2Ф (from 4 to 40°, with voltage and current set at 30 kV and 30 mA, 
respectively. 
 
 
In vitro AZT release assays from the double-coated Cal-Sil 
granules 
 
The release rate of AZT from the double coated Cal-Sil granules 
was followed during a 24 h timeframe using the afore mentioned 
dissolution apparatus (Dissolutor from American Lab, model AL 
1000, Charqueada, São Paulo, Brazil) and the dissolution method 
described in US Pharmacopeia 31 (2008), with 900 ml of simulated 
gastric fluid (pH 1.2) without pepsin as dissolution medium, at a 
constant temperature of 37 ± 0.5°C and under magnetic stirring set 
at 50 rpm. At predetermined time intervals, 5 ml-samples of 
dissolution medium were withdrawn and centrifuged at 3500 rpm for 
5 min. The supernatant was then collected carefully and filtered 
through a 0.25 µm pore size membrane filter and the concentration 
of dissolved AZT determined via spectrophotometry at a 
wavelength of 266 nm. The total volume of dissolution medium in 
the dissolutor was kept constant at all times via addition of 5 ml of 
fresh dissolution fluid with the same temperature, immediately after 
every sample withdrawal. All assays were performed in sextuplicate. 
 
 
Mathematical description of AZT release pattern from the 
double-coated Cal-Sil granules 
 
The quantitative analysis of the AZT release values produced in the 
dissolution tests becomes easier when mathematical models that 
express the dissolution results as a function of some characteristics 
of the dosage forms are utilized. Three mathematical models (Table 
1) were applied to describe AZT release  pattern  from  the  double- 
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Table 1. Representation of the 
mathematical models used to describe the 
release profiles. 
  
Model Equation 
Zero order   
First order  
Higuchi 
 
 
 
 
coated Cal-Sil granules, according to the work by Costa and Lobo 
(2001), where Qt is the amount of drug dissolved in time t, Q0 is the 
initial amount of the drug in solution, K0 is a zero-order constant, K1 
is a first-order proportionality constant, and KH is the Higuchi 
dissolution constant. R
2
 values were calculated via linear regression 
fittings of the dissolution models (Table 1) to the transformed 
experimental data. 
 
 
RESULTS AND DISCUSSION 
 
Structural morphology of the double-coated Cal-Sil 
granules with adsorbed AZT 
 
Double-coated, low density Cal-Sil-based floating 
granules with adsorbed AZT were prepared by wet gra-
nulation. The Cal-Sil granules with adsorbed AZT were 
coated with ethylcellulose, Eudragit
®
 L100 and HPMC, 
which can produce porous structures within the granules. 
The undissolved polymer particles produced irregular 
rough surfaces on the granules (Figure 1). 
 
 
Structural microanalysis of the Cal-Sil particles with 
adsorbed AZT, via scanning electron microscopy 
 
Figure 2a showed a SEM image of a low density Cal-Sil 
particle at ×5000 magnification, allowing observation of a 
porous and rough surface. The presence of pores 
suggested that Cal-Sil has a good capacity for drug 
loading. Figure 2b shows a SEM microphotograph of 
primarily coated Cal-Sil granule with adsorbed AZT 
(PCG), at ×1000 magnification, clearly showing some 
pores on the surface of the coated particle, thus demon-
strating that the polymer blend was not able to thoroughly 
coat the Cal-Sil particles. Hence, this PCG structure 
would not be able to increase sufficiently the diffusion 
layer of the granules so as to allow attainment of the 
desired AZT release rate. Figure 2c shows a SEM 
microphotograph of a secondarily coated Cal-Sil granule 
with adsorbed AZT (SCG), also at ×1000 magnification, 
now showing less pores on the particle surface. 
Therefore, increasing the diffusion layer can provide a 
modified and more controlled release of AZT from the 
Cal-Sil granules. 
 
 
 
 
Buoyancy and drug content 
 
Immediately after being sprinkled on the surface of the 
simulated liquid gastric fluid, the granules sunk to the 
bottom of the container. Despite the relatively high 
surface tension of simulated gastric fluid, the time taken 
for the double-coated Cal-Sil granules with adsorbed AZT 
to float (that is, the lag time) was only a few seconds. 
After this short lag time, all granules floated and re-
mained afloat for more than 12 h. After a 24 h timeframe, 
ca. 40 ± 3% of the granules still remained floating in the 
simulated gastric fluid. The short time needed for the 
granules to float can be attributed to the release of 
carbon dioxide produced in the reaction of (simulated) 
gastric HCl with the sodium bicarbonate present in the 
granules. On the other hand, the permanence of the 
granules on the surface of the simulated gastric fluid can 
be attributed to the high swelling capability of HPMC, 
which promoted swelling of the granules with concomitant 
decrease in density. Buoyancy of 100% of the granules 
for ca. 12 h was considered to be very good. The 
percentage of adsorbed AZT was 81.00 ± 14.66%, which 
may be considered a satisfactory drug loading efficiency 
despite the standard deviation of ±14.66%. 
 
 
Thermal analyses by Differential Scanning 
Calorimetry 
 
The thermograms of pure AZT and of both double-coated 
Cal-Sil granules with and without adsorbed AZT are 
displayed in Figure 3. The thermogram of pure AZT 
(Figure 3a) showed an endothermic peak at 125°C that 
corresponds to the AZT melting point. After the endo-
thermic fusion event, one can observe two consecutive 
exothermic events (between 225 and 250°C) probably 
implicated in AZT degradation, and another endothermic 
event (at 310°C). The results obtained are similar to 
those reported by Rodrigues et al. (2005) in a study 
about application of thermal analytical techniques for the 
characterization, purity determination, and degradation 
kinetics of AZT. The results obtained from the DSC 
analysis of the double-coated Cal-Sil granules without 
AZT (Figure 3b) and of the double-coated Cal-Sil gra-
nules with adsorbed AZT (Figure 3c) clearly suggest that 
AZT is in an amorphous form in the double-coated Cal-Sil 
granules (Figure 3c). The differences in peak size may be 
interpreted either as being related to the amount of AZT 
adsorbed in the Cal-Sil granules or as a decrease in the 
degree of crystallinity upon adsorption onto the Cal-Sil 
granules. 
 
 
X-ray Diffraction analyses (XRD) 
 
X-ray diffraction analytical techniques are especially 
significant for the analysis of solid materials. The decisive 
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Figure 1. Scanning electron microphotographs of double-coated Cal-Sil granules with 
adsorbed AZT (magnification: x50). 
 
 
 
advantage of X-ray diffraction methods over other 
analytical techniques is based on the unique character of 
the diffraction patterns of crystalline substances, the 
ability to distinguish between elements and their oxides, 
and the possibility to identify chemical compounds, 
polymorphic forms, and mixed crystals by a non-
destructive examination. The results obtained in the X-ray 
diffraction analysis performed to pure AZT, and to both 
double-coated Cal-Sil granules with and without 
adsorbed AZT, are displayed in Figure 4. Since the 
intensity of the peaks in the diffraction patterns also 
depends on the drug concentration, a decrease in the 
size of peaks was expected for the systems encom-
passing double-coated granules. Figure 4a showed the 
diffractogram of pure AZT, Figure 4b shows the 
diffractogram of double-coated Cal-Sil granules without 
AZT, and Figure 4c shows the diffractogram of double-
coated Cal-Sil granules with adsorbed AZT. The 
diffractogram of pure AZT (Figure 4a) indicated the 
crystalline structure of the drug while the diffractograms 
of both double-coated Cal-Sil granules with and without 
adsorbed AZT presented the same pattern, thus 
suggesting that AZT adsorbed to Cal-Sil and further 
double-coated with polymer may in fact be in an amor-
phous or crystalline state, hence confirming the results 
obtained in the thermal analyses via differential scanning 
calorimetry. Similar results have been  reported  by  other  
research groups (Cui et al., 2003; Gupta and Pathak, 
2008; El-Kamel et al., 2001; Mateovic-Rojnik et al., 
2005). 
 
 
Analysis by Fourier transform infrared (FTIR) 
spectroscopy 
 
The results obtained in the FTIR analyses performed are 
displayed in Figure 5. The FTIR spectra of pure AZT is 
displayed as Figure 5a while that of double-coated Cal-Sil 
granules with adsorbed AZT is displayed as Figure 5b. 
Both spectra of pure AZT and of double-coated Cal-Sil 
granules with adsorbed AZT exhibit characteristic peaks 
between 3,200 and 3,500 cm
−1
, which represented the 
wavelength range assigned to the O-H stretching band, a 
carbonyl group at 1,683 cm
−1
, and an azide group at 
2,083 cm
−1
. One peak at 1,380 cm
−1
 was assigned to 
methylene (CH2) and the one at 1281 cm
−1
 is assigned to 
C–O–C and C–OH groups. The intervals of the stretching 
peaks in the research effort entertained herein were 
similar to those reported by Araújo et al. (2003), and 
indicated the stable nature of AZT during the production 
process of the double-coated Cal-Sil granules. All the 
chemical functional groups of AZT were present in the 
FTIR spectra. The lower intensity of some peaks dis-
played in Figure 5b was due  to  the  dilution  effect  upon 
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Figure 2. Scanning electron microphotographs of (a) Cal-Sil particles (magnification: x5000), (b) 
Primary coated Cal-Sil granules (PCG) (magnification: ×1000), and (c) double-coated Cal-Sil granules 
(SCG) (magnification: ×1000). 
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Figure 3. Differential scanning calorimetry curves (DSC) of (a) pure AZT, (b) 
Double-coated Cal-Sil granules without AZT, and (c) Double-coated Cal-Sil 
granules with adsorbed AZT (SCG). 
 
 
 
 
Figure 4. X-ray diffractograms of (a) pure AZT, (b) Double-coated Cal-
Sil granules without AZT, and (c) Double-coated Cal-Sil granules with 
adsorbed AZT (SCG). 
 
 
AZT adsorption onto the Cal-Sil granules prior to double-
coating with the polymer. Comparison between Figures 
5a and 5b shows no peak displacement at all, denoting a 
full conservation of the spectrum profile, which can most 
likely mean that AZT virtually does not undergo chemical 
interaction with the polymer upon double-coating after its 
adsorption onto the Cal-Sil particles, just being carried by 
the gastroretentive system, which is  in  close  agreement  
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Figure 5. FTIR spectra of (a) pure AZT and (b) Double-coated Cal-Sil granules 
with adsorbed AZT (SCG). 
 
 
 
with the release profile observed for AZT (Figure 6). 
 
 
In vitro release pattern of AZT 
 
The release of AZT from the double-coated Cal-Sil 
granules in simulated gastric fluid (pH 1.2) is influenced 
more significantly by parameters such as the poly-
dispersity, the mean diameter of particles, the porosity, 
and the homogeneity of drug distribution pattern inside 
the particles. Mateovic-Rojnik et al. (2005) studied the 
correlation of some particle features in the release of 
ketoprofen, and concluded that the surface 
characteristics of the particles had a more pronounced 
effect on the release profile of the drug. Figure 6 displays 
the results obtained for the release pattern of AZT from 
the double-coated Cal-Sil granules in simulated gastric 
fluid. Since the acrylic polymer used for double-coating 
the Cal-Sil granules with adsorbed AZT is soluble at pH 
values above 6.0, it can be assumed that the drug 
release occurred by diffusion. From a close inspection of 
Figure 6, one can notice that ca. 30% of AZT was 
released from the granules in the first hour, 70% after 12 
h and 100% after 24 h. The initial burst effect may be 
attributed to the high aqueous solubility of AZT. The 
release profile obtained and displayed in Figure 6 is very 
likely related to the thickness of the diffusion layer and its 
saturation. During the whole dissolution test, the physical 
structure of the granules remained almost unchanged, 
except for a light swelling, thus virtually excluding the 
occurrence of any erosion of the granules. 
 
 
In vitro AZT release mechanisms study 
 
The release behavior of AZT from the floating double-
coated Cal-Sil granules was also investigated on the 
basis of theoretical dissolution models, including a zero-
order, a first-order, and Higuchi mathematical models. 
The regression coefficients (R
2
) produced via linear 
regression fittings of the dissolution models (Table 1) to 
the experimental data from in vitro release trials of AZT in 
simulated gastric fluid, after data transformation, were 
0.9522, 0.9677, and 0.9922, respectively for the zero-
order, first-order, and Higuchi mathematical models. As 
the plain diffusion process based on Fick’s law, the 
Higuchi matrix model was the one that better described 
the AZT release from double-coated Cal-Sil granules, 
which was indicative of a drug release indicating process 
by diffusion mechanism, excluding from further conside-
ration any erosion of the particles. This was in fact duly 
confirmed by the fact that all double-coated Cal-Sil 
granules remaining afloat in the simulated gastric fluid, 
far beyond the experimental timeframe. 
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Figure 6. In vitro release profile of AZT from the double-coated Cal-Sil granules with 
adsorbed drug, and associated standard deviations (n=6). 
 
 
 
Conclusions 
 
The present formulation study of AZT was performed in 
an attempt to prepare a floating drug delivery system 
consisting of a floating multiparticulate system. The use 
of low density calcium silicate proved successful, 
achieving a good loading rate. The double coating proved 
to be an effective method for producing intra-granular 
pores and achieving the desired release and buoyancy 
behavior. Low density Cal-Sil-based floating granules 
with adsorbed AZT (percentage of adsorbed AZT of 
81.00 ± 14.66%), prepared by wet granulation, and 
further double-coated with ethylcellulose, Eudragit
®
 L100 
and HPMC, produced irregular rough surfaces and 
porous structures within the granules. Immediately after 
being sprinkled on the surface of the simulated liquid 
gastric fluid, the granules sunk to the bottom of the con-
tainer but only for a few seconds, quickly floating towards 
the surface where they remained afloat. Buoyancy of 
100% of the granules for ca. 12 h was considered to be 
very good. The results obtained from the calorimetric 
analysis of the double-coated Cal-Sil granules without 
AZT and of the double-coated Cal-Sil granules with ad-
sorbed AZT clearly suggests that AZT is in an amorphous 
form upon adsorption onto the Cal-Sil granules prior to 
double-coating with polymer.  
The X-ray diffractogram of the pure (free) drug and the 
diffractograms   of  both  double-coated  Cal-Sil  granules  
with and without adsorbed AZT presented the same 
pattern, thus suggesting that AZT adsorbed to Cal-Sil and 
further double-coated with polymer was in fact in an 
amorphous state, hence confirming the results obtained 
both in the thermal analyses via differential scanning 
calorimetry and in the FTIR spectrophotometry. 
Additionally, the FTIR analyses performed allowed to 
conclude about the stable nature of AZT during the 
production process of the double-coated Cal-Sil granules, 
which can most likely mean that AZT virtually does not 
undergo chemical interaction with the polymer upon 
double-coating after its adsorption onto the Cal-Sil 
particles, just being carried by the gastroretentive system, 
which is in close agreement with the release profile 
observed for AZT. Since the acrylic polymer used for 
double-coating the Cal-Sil granules with adsorbed AZT is 
soluble at pH values above 6.0, it can be assumed that 
the drug release occurred by diffusion. 
The release profile obtained for AZT is very likely 
related to the thickness of the diffusion layer and its 
saturation. The Higuchi matrix model was the one that 
better described the AZT release from double-coated 
Cal-Sil granules, which was indicative of a drug release 
process via a diffusion mechanism, virtually excluding 
from further consideration of any erosion of the particles, 
this was in fact duly confirmed by the fact that all double-
coated Cal-Sil granules remained afloat in the simulated 
gastric fluid, far beyond the experimental timeframe. 
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